IVRO — InVitro International Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $2.26m
- $1.89m
- $0.72m
Annual income statement for InVitro International, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2006 September 30th | 2007 September 30th | 2008 September 30th | 2009 September 30th | 2010 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | PRESS | PRESS | PRESS | PRESS |
| Standards: | — | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.609 | 0.742 | 0.697 | 0.756 | 0.717 |
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.598 | 0.68 | 0.64 | 0.713 | 0.73 |
| Operating Profit | 0.011 | 0.061 | 0.056 | 0.042 | -0.013 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.016 | 0.069 | 0.065 | 0.051 | 0.006 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.016 | 0.069 | 0.065 | 0.051 | 0.006 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.016 | 0.069 | 0.065 | 0.051 | 0.006 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.016 | 0.069 | 0.065 | 0.051 | 0.006 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.001 | 0.004 | 0.004 | 0.003 | 0 |